Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Assets (2010 - 2026)

Updated

Ligand Pharmaceuticals' Assets came in at $2.19 billion for Q2 2026, up 130.4% from $948.6 million a year earlier and up 42.7% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Ligand Pharmaceuticals' Assets was $1.56 billion, up 65.7% from FY2024.

  • Assets has increased in each of the last three years, with a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
  • Going back by year, Assets was $941.77 million in FY2024 (+19.6%), $787.22 million in FY2023 (+3.2%), $762.67 million in FY2022 (-41.2%) and $1.3 billion in FY2021 (-4.7%).
  • The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2010.
  • Year-over-year, Assets has increased for five consecutive quarters, with growth averaging 46.5% over the last eight quarters.
  • The fastest year-over-year change in Assets over five years came in Q2 2026 (growth of 130.4%), and the weakest in Q4 2022 (a decline of 41.2%).
  • Business Quant data shows LGND's Assets at $1.53 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.48 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn - 2.19 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.19 Bn
Mar 31, 2026 1.53 Bn
Dec 31, 2025 1.56 Bn
Sep 30, 2025 1.48 Bn
Jun 30, 2025 948.60 Mn
Mar 31, 2025 905.44 Mn
Dec 31, 2024 941.77 Mn
Sep 30, 2024 954.87 Mn
Jun 30, 2024 866.41 Mn
Mar 31, 2024 913.87 Mn
Dec 31, 2023 787.22 Mn
Sep 30, 2023 769.23 Mn
Jun 30, 2023 758.11 Mn
Mar 31, 2023 811.08 Mn
Dec 31, 2022 762.67 Mn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 1.08 Bn
Mar 31, 2022 1.11 Bn
Dec 31, 2021 1.30 Bn
Sep 30, 2021 1.27 Bn
API Access

Ligand Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=LGND&period=max&api_key=YOUR_API_KEY